arrow
返回

Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis

delete2020-10-14
delete18
delete
OA
AI
N
Neta Gotlieb
N
Naama Schwartz
S
Shira Zelber‐Sagi
G
Gabriel Chodick
V
Varda Shalev
O
Oren Shibolet *
DOI:10.3748/wjg.v26.i38.5849delete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
BACKGROUND Liver cirrhosis is a significant source of morbidity and mortality worldwide. The disease is usually indolent and asymptomatic early in its course while many cirrhotic patients are diagnosed late when severe complications occur. A major challenge is to diagnose advanced fibrosis as early as possible, using simple and non-invasive diagnostics tools. Thrombocytopenia represents advanced fibrosis and portal hypertension (HTN) and most non-invasive scores that predict liver fibrosis incorporate platelets as a strong risk factor. However, little is known about the association between longitudinal changes in platelet counts (PTC), when still within the normal range, and the risk of cirrhosis. AIM To explore whether platelet counts trajectories over time, can predict advanced liver fibrosis across the different etiologies of liver diseases. METHODS A nested case-control study utilizing a large computerized database. Cirrhosis cases (n = 5258) were compared to controls (n = 15744) matched for age and sex at a ratio of 1:3. All participants had multiple laboratory measurements prior to enrollment. We calculated the trends of PTC, liver enzymes, bilirubin, international normalized ratio, albumin and fibrosis scores (fibrosis-4 and aspartate transaminase-to-platelet ratio index) throughout the preceding 20 years prior to cirrhosis diagnosis compared to healthy controls. The association between PTC, cirrhosis complications and fibrosis scores prior to cirrhosis diagnosis was investigated. RESULTS The mean age in both groups was 56 (SD 15.8). Cirrhotic patients were more likely to be smokers, diabetic with chronic kidney disease and had a higher prevalence of HTN. The leading cirrhosis etiologies were viral, alcoholic and fatty liver disease. The mean PTC decreased from 240000/mu L to 190000/mu L up to 15 years prior to cirrhosis diagnosis compared to controls who's PTC remained stable around the values of 240000/mu L. This trend was consistent regardless of sex, cirrhosis etiology and was more pronounced in patients who developed varices and ascites. Compared to controls whose values remained in the normal range, in the cirrhosis group aspartate aminotransferase and alanine aminotransferase, increased from 40 U/L to 75 U/L and FIB-4 increased gradually from 1.3 to 3 prior to cirrhosis diagnosis. In multivariable regression analysis, a decrease of 50 units in PTC was associated with 1.3 times odds of cirrhosis (95%CI 1.25-1.35). CONCLUSION In the preceding years before the diagnosis of cirrhosis, there is a progressive decline in PTC, within the normal range, matched to a gradual increase in fibrosis scores.
Keyword:
Cirrhosis
Platelets
Count
Trend
Prediction
Range
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

World Journal of Gastroenterology 封面图
World Journal of Gastroenterology
IF:
5.4
论文数:
2.1W
被引数:
5.1W

机构

T
tel aviv sourasky medical center
学者数:
2.9K
论文数: 2.0K
被引数: 2
T
Tel Aviv University
学者数:
3.7W
论文数: 3.0W
被引数: 3.6W
引用论文

引用论文

err分享
err收藏
Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk of variceal bleeding
err2016-12-06
err69
PREAI
errMarot, Astrid; Trepo, Eric; Doerig, Christopher; Schoepfer, Alain; Moreno, Christophe; Deltenre, Pierre
err分享
err收藏
Invoking the “expectant” triage category: Can we make the paradigm shift?
err2017-07-01
err0
PREAI
errAudrey Dadoun, MDCM, MBA, FRCPC; Elene Khalil, MDCM, FRCPC, FAAP; Ilana Bank, MDCM, FRCPC, FAAP
err分享
err收藏
Platelets in chronic liver disease, from bench to bedside
err2019-12-01
err49
errOAAI
errRamadori, Pierluigi; Klag, Thomas; Malek, Nisar Peter; Heikenwalder, Mathias
err分享
err收藏
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
err2006-06-01
err3.5K
errOAAI
errSterling, Richard K.; Lissen, Eduardo; Clumeck, Nathan; Sola, Ricard; Correa, Mendes Cassia; Montaner, Julio; Sulkowski, Mark S.; Torriani, Francesca J.; Dieterich, Doug T.; Thomas, David L.; Messinger, Diethelm; Nelson, Mark
err分享
err收藏
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients
err2016-04-01
err244
PREAI
errKim, W. Ray; Berge, Thomas; Asselah, Tarik; Flisiak, Robert; Fung, Scott; Gordon, Stuart C.; Janssens, Harry L. A.; Lampertico, Pietro; Lau, Daryl; Bornstein, Jeffrey D.; Schall, Raul E. Aguilar; Dinh, Phillip; Yee, Leland J.; Martins, Eduardo B.; Lim, Seng Gee; Loomba, Rohit; Petersen, Joerg; Buti, Maria; Marcellin, Patrick
err分享
err收藏
Utility and limitations of APRI and FIB4 to predict staging in a cohort of nonselected outpatients with hepatitis C
err2016-05-01
err22
errOAAI
errde Oliveira, Ana Claudia; El-Bacha, Ibrahin; Vianna, Monica V.; Parise, Edison R.
err分享
err收藏
学者 查看更多内容